Clarametyx has promoted Steve St. Onge to Chief Business Officer and hired Brendan Doran as Senior Vice President of Clinical Development.

The Harvard University Graduate School of Arts and Sciences in Cambridge, Mass., and Harvard Business School in Boston recently unveiled a new joint master’s degree program in the life sciences. The ...

NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- IO Biotech (IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, ...

Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, ...

Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced the appointment of Gregory D. Kunst as chief executive officer and member of the board of ...

Interested in transforming breakthrough research into real-world therapies? This session introduces the MS/MBA Biotechnology Program — designed for life scientists who want to lead in biotech, pharma, ...

Biotechnology is revolutionizing industries and transforming human health worldwide. Today’s biotech leaders must bridge laboratory breakthroughs with business strategy to bring life-changing ...

ADZE is thrilled to welcome Dr. Paola Grandi to our team as we advance our pipeline of systemically deliverable oncolytic immunotherapies into the clinic. ADZE is thrilled to welcome Dr. Paola Grandi ...